AstraZeneca (AZN)

Company name:AstraZeneca
Company Description:A group engaged in R&D; manufacture & marketing of prescription pharmaceuticals & biological products for healthcare areas such as cardiovascular; neuroscience; oncology; respiratory & inflammation
EPIC:AZNTrading Currency:GBX
Market Sector:FE00ISIN:GB0009895292
Market Segment:SET0Share Type:DE
WWW Address:http://www.astrazeneca.com/Description:ORD SHS $0.25
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 5,401.00 .advfn.com/imagesnew/2/us/down -107.0 [-1.94] 5,410.00 5,412.00 5,481.00 5,481.00 5,400.00 2,322,968
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 68,357.25 1,265.64 1.17 218.48 226.75 24.72 4.20 5,520.00 - 3,680.00

AstraZeneca Key Figures

(at previous day's close)
Market Cap.68,357.25m
Shares In Issue1,265.64m
Prev. Close5,508.00
PE Ratio24.72 
Dividend Yield4.20%
EPS - basic218.48p
Dividend PS226.75p
Dividend Cover- 
Cash Flow PS265.22p
Return On Equity (ROE)23.56%
Operating Margin15.44%
PEG Factor1.02 
EPS Growth Rate24.22%
Dividends PS Growth Rate-%
Net Debt33,072.03m
Gross Gearing73.34%
Quick Assets9,733.98m
Net Working Capital-730.45m
Intangibles / Fixed Assets81.47%
Turnover PS1,471.77p
Pre-Tax Profit PS227.27p
Retained Profit PS-3.97p
Cash PS321.07p
Net Cash PS-655.07p
Net Tangible Asset Value PS *-1,560.58p
Net Asset Value PS1,066.56p
Spread2.00 (0.04%) 

AstraZeneca Balance Sheet

LSE:AZN:Liabilities+EQLSE:AZN:Assets

Share Price Performance

Sample Period HighLow
1 week5,520.005,265.00
4 weeks5,520.005,170.00
12 weeks5,520.004,521.00
1 year5,520.003,680.00

Share Price Chart (5 years)

AstraZeneca Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week5,289.00112.002.125,265.002.01-
4 weeks5,225.00176.003.375,170.001.98-
12 weeks4,931.00470.009.534,521.002.33-
26 weeks4,383.501,017.5023.214,136.502.68-
1 year3,705.001,696.0045.783,680.002.86-
3 years4,331.001,070.0024.713,680.002.66-
5 years2,870.002,531.0088.192,786.002.60-

AstraZeneca Key Management Ratios

AstraZeneca Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio90.59 
PE Ratio24.72 
Tobin's Q Ratio 1.11 
Tobin's Q Ratio (excl. intangibles)2.80 
Dividend Yield4.20%
Market-to-Book Ratio5.68 
Price-to-Pre-Tax Profit PS23.76 
Price-to-Retained Profit PS-1,361.47 
Price-to-Cash Flow PS20.36 
Price-to-Sales PS3.67 
Price-to-Net Tangible Asset Value PS-3.74 
Price-to-Cash PS16.82 
Net Working Capital PS-57.71 
Price Pct to Working Capital PS-93.58%
Earnings Yield4.05%
Average PE21.31 
Years in average5 
PE to PE average116.00%

AstraZeneca Financial Ratios

(Leverage Ratios)
Debt Ratio64.74%
Debt-to-Equity Ratio1.84 
Debt-to-Equity Ratio (excl. Intgbl)-1.36 
Debt-to-Equity Market Value0.36 
Net Gearing65.32%
Net Gearing (excl. Intangibles)175.41%
Gross Gearing73.34%
Gross Gearing (excl. Intangibles)196.96%
Gearing Under 1 Year24.40%
Gearing Under 1 Year (excl. Intgbl)65.53%
Assets/Equity3.75 
Cash/Equity30.10 
(Liquidity Ratios)
Net Working Capital to Total Assets-1.44%
Current Ratio0.94 
Quick Ratio (Acid Test)0.79 
Liquidity Ratio0.33 
Cash & Equiv/Current Assets34.96%
(Solvency Ratios)
Enterprise Value90,544.56m
CFO/Sales0.18 
CFO/Attributable Profit1.18 
CFO/Assets0.07 
CFO/Debt0.09 
Total Debt/Equity Market Value0.54 
Total Debt/Sales1.99 
Total Debt/Pre-Tax Profit12.91 
Total Debt37,135.69m
Total Debt/Net Current Assets-50.84%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth41.39%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)
1.17411.4223
Alpha (60-Mnth)Alpha (36-Mnth)
0.00480.0013

AstraZeneca Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)7.51%
Return On Assets (ROA)4.62%
Net Profit Margin15.21%
Assets Turnover0.30 
Return On Equity (ROE)23.56%
Return On Investment (ROI)6.12%
Dividend Payout Ratio101.08%
Plowback Ratio-1.08%
Growth from Plowback Ratio-0.18%
Net Income Of Revenues-0.27%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.12 
Fixed Assets Turnover0.41 
Current Assets Turnover1.17 
Net Working Capital Turnover 
Inventory Turnover8.32 
(Other Operating Ratios)
Total Assets-to-Sales3.29 
Debtors-to-Sales43.52%
Debt Collection Period158.84Days

AstraZeneca Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
02 Feb 2017FinalUSX190.0012/31/201512/31/201602/16/201702/17/201703/20/2017280.00
28 Jul 2016InterimUSX90.0012/31/201512/31/201608/11/201608/12/201609/12/2016-
04 Feb 2016FinalUSX190.0012/31/201412/31/201502/18/201602/19/201603/21/2016280.00
30 Jul 2015InterimUSX90.0012/31/201412/31/201508/13/201508/14/201509/14/2015-
05 Feb 2015FinalUSX190.0012/31/201312/31/201402/19/201502/20/201503/23/2015280.00
31 Jul 2014InterimUSX90.0012/31/201312/31/201408/13/201408/15/201409/15/2014-
06 Feb 2014FinalUSX190.0012/31/201212/31/201302/19/201402/21/201403/24/2014280.00
01 Aug 2013InterimUSX90.0012/31/201212/31/201308/14/201308/16/201309/16/2013-
31 Jan 2013FinalUSX190.0012/31/201112/31/201202/13/201302/15/201303/18/2013280.00
26 Jul 2012InterimUSX90.0012/31/201112/31/201208/08/201208/10/201209/10/2012-
02 Feb 2012FinalUSX195.0012/31/201012/31/201102/15/201202/17/201203/19/2012280.00
28 Jul 2011InterimUSX85.0012/31/201012/31/201108/03/201108/05/201109/12/2011-
27 Jan 2011FinalUSX185.0012/31/200912/31/201002/02/201102/04/201103/14/2011255.00
29 Jul 2010InterimUSX70.0012/31/200912/31/201008/02/201008/04/201009/13/2010-
28 Jan 2010FinalUSX171.0012/31/200812/31/200902/03/201002/05/201003/15/2010230.00
30 Jul 2009InterimUSX59.0012/30/200806/30/200908/05/200908/07/200909/14/2009-
29 Jan 2009FinalUSX150.0012/31/200712/31/200802/04/200902/06/200903/16/2009205.00
31 Jul 2008InterimUSX55.0012/30/200706/30/200808/08/200808/06/200809/15/2008-
31 Jan 2008FinalUSX135.0012/31/200612/31/200702/06/200802/08/200803/17/2008187.00
26 Jul 2007InterimUSX52.0006/30/200606/30/200708/08/200708/10/200709/17/2007-
01 Feb 2007FinalUSX123.0012/31/200512/31/200602/07/200702/09/200703/19/2007172.00
27 Jul 2006InterimUSX49.0012/30/200506/30/200608/09/200608/11/200609/18/2006-
01 Feb 2006FinalUSX92.0012/31/200412/31/200502/08/200602/10/200603/20/2006130.00
29 Jul 2005InterimUSX38.0012/30/200406/30/200508/10/200508/12/200509/19/2005-
27 Jan 2005FinalUSX64.5012/31/200312/31/200402/09/200502/11/200503/21/200594.00
22 Jul 2004InterimUSX29.5012/30/200306/30/200408/11/200408/13/200409/20/2004-
29 Jan 2004FinalUSX54.0012/31/200212/31/200302/18/200402/20/200404/06/200479.50
24 Jul 2003InterimUSX25.5012/30/200206/30/200308/20/200308/22/200310/06/2003-
30 Jan 2003FinalUSX47.0012/31/200112/31/200202/19/200302/21/200304/07/200370.00
25 Jul 2002InterimUSX23.0012/30/200106/30/200208/21/200208/23/200210/07/2002-
31 Jan 2002FinalUSX47.0012/31/200012/31/200102/20/200202/22/200204/08/200270.00
26 Jul 2001InterimUSX23.0012/30/200006/30/200108/22/200108/24/200110/05/2001-
08 Feb 2001FinalUSX47.0012/31/199912/31/200002/21/200102/23/200104/09/200170.00
01 Aug 2000InterimUSX23.0012/30/199906/30/200009/04/200009/08/200010/23/2000-
24 Feb 2000FinalUSX47.0012/31/199812/31/199903/06/200003/10/200004/17/200070.00
03 Aug 1999InterimUSX23.0012/30/199806/30/199909/06/199909/10/199910/25/1999-

AstraZeneca Fundamentals

 31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
turnover25,711.00100.00%26,095.00100.00%24,708.00100.00%23,002.00100.00%m
pre tax profit3,267.0012.71%1,246.004.77%3,069.0012.42%3,552.0015.44%m
attributable profit2,556.009.94%1,233.004.73%2,825.0011.43%3,499.0015.21%m
retained profit-905.00-3.52%-2,288.00-8.77%-661.00-2.68%-62.00-0.27%m
eps - basic204.00 98.00 223.00 277.00 
eps - diluted204.00 98.00 223.00 277.00 
dividends per share280.00 280.00 280.00 280.00 

AstraZeneca Balance Sheet

 31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
LSE:AZN:Liabilities+EQLSE:AZN:AssetsLSE:AZN:Liabilities+EQLSE:AZN:AssetsLSE:AZN:Liabilities+EQLSE:AZN:AssetsLSE:AZN:Liabilities+EQLSE:AZN:Assets
 31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
ASSETS
fixed assets fixed assets5,818.0010.41%6,010.0010.26%6,413.0010.67%6,848.0010.95%m
intangibles intangibles26,028.0046.56%32,531.0055.52%34,514.0057.40%39,244.0062.76%m
fixed investments fixed investments1,482.002.65%1,842.003.14%1,604.002.67%2,080.003.33%m
current assets - other current assets - other--%--%--%--%m
stocks stocks1,909.003.42%1,960.003.34%2,143.003.56%2,334.003.73%m
debtors debtors11,445.0020.47%9,892.0016.88%9,210.0015.32%7,002.0011.20%m
cash & securities cash & securities9,217.0016.49%6,360.0010.85%6,240.0010.38%5,018.008.03%m
TOTAL55,899.00100%58,595.00100%60,124.00100%62,526.00100%m
LIABILITIES
creditors - short creditors - short16,051.0028.71%17,330.0029.58%14,869.0024.73%15,256.0024.40%m
creditors - long creditors - long16,595.0029.69%21,619.0036.90%26,746.0044.48%30,601.0048.94%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL32,646.0058.40%38,949.0066.47%41,615.0069.22%45,857.0073.34%m
EQUITY
ord cap, reserves ord cap, reserves23,224.0041.55%19,627.0033.50%18,490.0030.75%14,854.0023.76%m
prefs, minorities prefs, minorities29.000.05%19.000.03%19.000.03%1,815.002.90%m
TOTAL23,253.0041.60%19,646.0033.53%18,509.0030.78%16,669.0026.66%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

AstraZeneca Cash Flow Statement

31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
Operating CF7,400.007,058.003,324.004,145.00m
Pre-Financing CF4,511.0026.00-915.00176.00m
Retained CF1,464.00-2,679.00-37.00-1,148.00m

AstraZeneca Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Nyenburgh Holding B.V.Market Maker(MME)Broker/DealerNYBBNYENNL2B
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:us D:20170626 03:37:21